Walk “The Way” with her
So MORE women with breast cancer become Survivors
Join Her (Leslie) in funding the Density MATTERS study at the Mayo Clinic as she walks the 500 mile Camino de Santiago Pilgrimage from France to Santiago de Compostela in Spain.
(The Frances Way)
Follow Leslie on her journey:
Dense Breasts &
Molecular Breast Imaging (MBI)
Up to half of all women in the world have dense breast tissue
Dense tissue AND cancer both look white on a mammogram, and therefore many cancers can be obstructed from view on mammogram images.
Mammograms detect less than half of all cancers in women with dense breast tissue.
This leaves cancer to grow and ultimately travel to other parts of the body (metastasize) in those women whose cancers go undetected. There is currently NO CURE for metastatic breast cancer . . . 40,000 women per year die of metastatic breast cancer.
Dense breast tissue alone is a high risk factor for breast cancer.
Having dense breast tissue is a risk factor for getting breast cancer, equivalent to having a family member with the disease.
Therefore, mammography screening is inadequate for half of the female population, who are naturally at higher risk.
Better breast cancer early detection is just around the corner . . .
A new technology called Molecular Breast Imaging (MBI) has proven to detect 3-4 times more breast cancers at an early stage than standard mammography in women with dense breast tissue. Click to see results.
What’s the next step necessary so MORE women with breast cancer become SURVIVORS?
Funding the Density MATTERS Study
The Density MATTERS Study
Seeks to prove these 3 things . . .
. . . that MBI detects more cancers than 3D mammo.(tomosynthesis), revealing those left to grow undetected on mammography.
. . . that cost-per-cancer detected is lower for MBI than mammography.
. . . that the radiation dose of MBI will be equal to mammography with tomosynthesis.